STAT3 and hepatocellular carcinoma: Likewise, we found no significant connection between STAT3 rs2293152 polymorphism and CHB-related HCC risk either (G vs. C, OR = 1.07, 95% CI: 0.95–1.20, PA=0.24; GG + GC vs. CC: OR = 1.06, 95% CI: 0.88–1.27, PA= 0.57; GG vs. GC + CC: OR = 1.14, 95% CI: 0.94–1.38, PA=0.17).